Article ID Journal Published Year Pages File Type
8659065 Diabetes & Metabolic Syndrome: Clinical Research & Reviews 2017 5 Pages PDF
Abstract
Results from this study demonstrate that PCSK9 correlates with some components of metabolic syndrome and central obesity in young females. Such findings support the suggestion of using PCSK9 inhibitors in the management of MetS to modify risk for development of CVD.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Cardiology and Cardiovascular Medicine
Preview
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and metabolic syndrome components among young adult females
Authors
, , , , ,